Teva Pharmaceutical Industries announced the launch of an authorized generic of Actos 15, 30 and 45mg. Actos is marketed by Takeda Pharmaceuticals U.S.A., Inc. and used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. The brand product had annual sales of approximately $2.7B in the United States, based on IMS sales data as of June 30, 2012.
Gap Inc reported a higher first-quarter profit on Thursday, helped by a rise in same-store sales at its Old Navy …